Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain

Completed · Phase 2

Conditions studied: Acute Pain

In brief

The purpose of this study is to determine the safety and speed of onset of 2mg intravenous hydromorphone (Dilaudid) in patients weighing at least 150 lbs presenting to the emergency department with acute severe pain

Key facts

Study ID

NCT00305110

Run by

Montefiore Medical Center

People needed

298

Starts

2006-01-01

Expected to finish

2006-10-01

Last updated by the study team

2018-08-20

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age greater than 21 years
• Age less than 65 years of age
• Pain with onset within 7 days
• ED attending physician's judgment that patient's pain warrants use of morphine
• Normal mental status

You may not qualify if…

• Prior use of methadone
• Use of other opioids or tramadol within past seven days
• Prior adverse reaction to hydromorphone.
• Chronic pain syndrome
• Alcohol intoxication
• SBP <90 mm Hg
• Use of MAO inhibitors in past 30 days
• C02 measurement greater than 46

Where it is running

• Montefiore Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.